Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 19

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 19
---
atively determined that each of Ms. Burks, Ms. Garinois-Melenikiotou, Mr. McCormick, and Mr. Mead qualifies as “independent” under NYSE’s additional standards applicable to audit committee members and Rule 10A-3 of the Exchange Act of 1934, as amended (the “Exchange Act”). In addition, our Board of Directors has determined that Ms. Garinois-Melenikiotou, Mr. McCormick, and Mr. Mead each qualify as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K. The determination by our Board of Directors for Mr. McCormick was made based on experience and education which demonstrate his attributes as an audit committee financial expert, including the fact that he has been the chief financial officer of several medical technology companies and is a Certified Public Accountant (inactive), holding a degree in accounting and an M.B.A. Both Ms. Garinois-Melenikiotou and Mr. Mead also have education and experience supporting their determination by the Board of Directors as audit committee financial experts, including that both have M.B.A. degrees and financial oversight experience, with Ms. Garinois-Melenikiotou gaining this experience as a president at Johnson & Johnson and Mr. Mead gaining this experience as a CEO of several medical technology companies. Organization and Compensation Committee Our Organization and Compensation Committee oversees our human capital strategies and programs, and our compensation policies, plans, and benefits programs. The committee is responsible for, among other things:

| • | reviewing and approving corporate goals and objectives with respect to the compensation of our CEO, evaluating our CEO’s performance in light of these goals and objectives, and setting the CEO’s compensation; |

| • | reviewing and approving the compensation of our other executive officers; |

| • | reviewing and making recommendations to our Board of Directors regarding director compensation; |

| • | reviewing and approving or making recommendations to our Board of Directors regarding our management incentive program and other cash incentive plans for executive officers, and equity-based incentive plans and arrangements; |

| • | reviewing the Company’s human capital management strategies, programs, and initiatives, including succession planning for executive officers and other senior executives; |

| • | providing support to the Nominating and Corporate Governance Committee in overseeing the Company’s strategy, policies, and practices and related reporting with respect to significant sustainability matters, with a focus on social matters; |

| • | overseeing the Company’s stock ownership guidelines and policy